Patent Assignment
Reel/Frame 029198/0340
Change of Name
Recorded: 2012-10-25
Pages: 5
Assignor
AMYLIN PHARMACEUTICALS, INC.
Executed: 2012-08-08
Assignee
AMYLIN PHARMACEUTICALS, LLC
9360 TOWNE CENTRE DRIVE, ATTN: INTELLECTUAL PROPERTY GROUP, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(21)
Treatment of Hibernating Myocardium and Diabetic Cardiomyopathy with a Glp-1 Peptide
Methods of Treating Obesity Using Pyy[3-36]
Compositions and Methods for Treating Peripheral Vascular Disease
Formulations for Amylin Agonist Peptides
Novel Exendin Agonist Compounds
Patent:
7,157,555 →
Application:
10/181,102 →
Exendins, Exendin Agonists, and Methods for Their Use
Methods and Compositions for Treating Polycystic Ovary Syndrome
Pseudo Native Chemical Ligation
Nucleophile-Stable Thioester Generating Compounds, Methods of Production and Use
Use of Amylin Agonists to Modulate Triglycerides
Application:
10/337,979 →
Publication:
US 2003/0130177
Native Chemical Ligation with Three or More Components
Chemical Peptide Ligation with Three or More Components
Post-Cleavage Sulfur Deprotection for Convergent Protein Synthesis by Chemical Ligation
Carboxy Protection Strategies for Acidic C-Terminal Amino Acids in Chemical Ligation of Oligopeptides
Water-Soluble Thioester and Selenoester Compounds and Methods for Making and Using the Same
Novel Methods and Compositions for Enhanced Transmucosal Delivery of Peptides and Proteins
Amylin Family Peptides
Methods and Compositions for Treating Polycystic Ovary Syndrome
Treatment of Pancreatitis with Amylin
Method for Enhanced Parenteral Nutrition
Methods for Affecting Body Composition
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Oct 1, 2012
From: ELI LILLY AND COMPANY
To: AMYLIN PHARMACEUTICALS, INC.
Reel/Frame 029057/0342 →
Amylin Pharmaceuticals, Llc Assigns an Equal and Undivided One-Half of Its Entire Right, Title and Interest to Astrazeneca Pharmaceuticals Lp
Oct 26, 2012
From: AMYLIN PHARMACEUTICALS, LLC
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 029195/0555 →